obesity

  1. madman

    The Diabetes Pandemic: What You Need to Know

    https://vimeo.com/894561902?share=copy 1:50-18:23
  2. madman

    Anti-Obesity Pharmacotherapy for Long-Term Obesity Management

    Dr. Carolyn T. Bramante, MD, MPH presented a grand round on Anti-Obesity Pharmacotherapy for Long-Term Obesity Management. She discussed the complexity of obesity as a disease, the physiological and genetic factors affecting it, the importance of individualizing treatment, and the effectiveness...
  3. madman

    The complex relation between OSA, hypogonadism, and TRT

    Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, which are also associated with male hypogonadism (MH). Therefore, obesity has been classically identified as the most evident...
  4. madman

    Pros & Cons of GLP-1 Weight Loss Drugs

    In this video, Mark Scholz and Mark Moyad discuss the pros and cons of weight loss drugs, particularly those that have shown significant weight loss results in patients. They emphasize that these drugs are not for cosmetic purposes, but for individuals with severe weight-related health issues...
  5. madman

    Tirzepatide Bests Semaglutide For A1c, Weight Loss

    https://www.hcplive.com/view/tirzepatide-bests-semaglutide-for-a1c-weight-loss-in-indirect-comparison-of-clinical-trial-data A network meta-analysis suggests tirzepatide may be more effective than semaglutide in reducing HbA1c and body weight in type 2 diabetes but may increase gastrointestinal...
  6. madman

    Making Sense of Semaglutide in Type 1 Diabetes

    https://www.hcplive.com/view/diabetes-dialogue-making-sense-of-semaglutide-in-type-1-diabetes In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and...
  7. madman

    Obesity - functional hypogonadism and fertility disorders

    Abstract Obesity is currently one of the most serious public health problems which affect up to 30-40% of the population, and its prevalence is higher in men than in women. Complications of obesity include atherosclerosis, cardiovascular diseases, and type 2 diabetes mellitus, but it also has a...
  8. madman

    Obesity and Male Infertility

    This health chat features Dr. Anthony Leeds and Dr. Channa Jayasena discussing the link between obesity and male infertility. Key Takeaways: *They talk about the global scale of fertility problems and the significant drop in male infertility rates since the 1970s. *The rising prevalence of...
  9. madman

    Semaglutide Could Eliminate Need for Insulin in Type 1 Diabetes

    https://www.hcplive.com/view/semaglutide-could-eliminate-need-for-insulin-in-type-1-diabetes A case series of 10 patients with newly diagnosed type 1 diabetes provides insight into the beneficial effects of off-label semaglutide use on insulin use, HbA1c, and fasting C-peptide levels among...
  10. madman

    Pros and Cons of the New Weight Loss Medications

    Abstract Purpose of Review The history of multiple weight loss medications has been a concerning paradox based on an increased cardiovascular risk despite significant reductions in adipose tissue and weight. A new class of weight loss medications could change this past narrative based on...
  11. madman

    Future therapies for obesity

    Obesity is a chronic disease associated with increased morbidity and mortality. Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications, but it is not scalable at the population level. Over the past few years, gut hormone-based...
  12. madman

    Comparing Weight Loss Modalities: Medical vs. Surgical

    In this episode of Better Edge, Dr. Veronica Johnson and Dr. Eric Hungness from Northwestern Medicine discuss weight loss modalities. They highlight the effectiveness of weight loss surgery in addressing obesity and its associated medical problems. They also explore the evolution of non-surgical...
  13. madman

    Management of Menopause in Patients with Obesity

    Introduction (00:00) Prof. John Stevenson (02:04) Q&A (22:20) Prof. Santiago Palacios (29:00) Q&A (53:57)
  14. madman

    T therapy may benefit men with diabetes and obesity but remains controversial

    https://www.healio.com/news/endocrinology/20230412/testosterone-therapy-may-benefit-men-with-diabetes-and-obesity-but-remains-controversial An increasing number of studies are reporting that testosterone therapy may not only normalize testosterone levels for men but may also provide...
  15. madman

    Efficacy and Cardiovascular Safety of TRT in Men with LOH Due to Obesity ± T2DM

    A Systematic Review of Studies Assessing Efficacy and Cardiovascular Safety of Testosterone Replacement Therapy in Men with Late‑onset Hypogonadism Due to Obesity ± Type 2 Diabetes Mellitus (2023) Vinod Abichandani, Atul Kalhan Background: There is a lack of consensus regarding the efficacy...
  16. M

    Lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs”

    Has anyone done a DEXA scan before and during use of any GLP-1 agonists (semaglutide, tizepatide) to assess body composition? In Peter Attia's recent blog, he eludes to the fact the GLP-1 agonists can cause loss of lean mass (in addition to fat loss), of particular concern in non-obese persons...
  17. C

    Looking for Semaglutide in Oklahoma

    I live in Oklahoma, have been struggling with weight my whole life. My wife and her friends are all on semaglutide and have lost an enormous amount of weight. My insurance doesn’t cover it. Do y’all know of any weight loss clinics that can get me the generic version for cheap?
  18. D

    Paediatricians now recommend drugs and surgery for kids with obesity

    "Children as young as 12 with obesity should now consider taking weight-loss drugs, and those as young as 13 with severe obesity should consider metabolic or bariatric surgery, according to aggressive new guidelines released Monday by the American Academy of Pediatrics."...
  19. madman

    Semaglutide in Adolescents with Obesity

  20. madman

    Once-Weekly Semaglutide in Adolescents with Obesity

    Once-Weekly Semaglutide in Adolescents with Obesity (2022) Daniel Weghuber, M.D., Timothy Barrett, Ph.D., Margarita Barrientos-Pérez, M.D., Inge Gies, Ph.D., Dan Hesse, Ph.D., Ole K. Jeppesen, M.Sc., Aaron S. Kelly, Ph.D., Lucy D. Mastrandrea, M.D., Rasmus Sørrig, Ph.D., and Silva Arslanian...
  21. madman

    Anti-Obesity Medications and Investigational Agents

    Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 Harold E. Bays, Angela Fitch, Sandra Christensen, Karli Burridge, Justin Tondt ABSTRACT Background: This “Anti-Obesity Medications and Investigational Agents: An...
  22. madman

    The metabolic role of prolactin

    The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations (2022) Giovanni Corona, Giulia Rastrelli, Paolo Comeglio, Federica Guaraldi, Diego Mazzatena, Alessandra Sforza , Linda Vignozzib and Mario Maggi ABSTRACT Introduction: Hyperprolactinemia has...
  23. madman

    Tirzepatide - First in a new class of diabetes medication (Part 2)

    Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.
  24. madman

    Tirzepatide - First in a new class of diabetes medication (Part 1)

    Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.
  25. madman

    The Men's Health Guide to Good Health and Even Better Fertility Rates

    CCRM Fertility's Dr. Brian Levine had the chance to sit down with Dr. Robert Mordkin, Dr. Peter Schlegel, and Registered Dietician & Nutritionist Amy Shapiro to talk about all things men's health. Key Moments * Peter Schlegel *Effects of Obesity *Fertility *Is Fertility a Big Problem...
  26. madman

    Factors Contributing to the Low Testosterone Epidemic with Dr. Abe Morgentaler

    The data shows that men's testosterone levels have decreased over time. Obesity, stress, and phytoestrogens are partly to blame. Listen as Dr. Abe Morgentaler explains some of the potential reasons for this trend.
  27. madman

    Once-Weekly Semaglutide for Weight Management

    Once-Weekly Semaglutide for Weight Management: A Clinical Review (2022) Abby Fornes, PharmD, Jamie Huff, PharmD, BCACP, BC-ADM, Roger Iain Pritchard, PharmD, BCACP, and Miranda Godfrey Abstract Objective: To review the efficacy, safety, and role of the glucagon-like peptide-1 (GLP-1)...
  28. madman

    Once-Weekly Tirzepatide for Obesity

    Here are the key points from the video titled "Once-Weekly Tirzepatide for Obesity | NEJM": Study Objective: The trial investigated the effectiveness of the type 2 diabetes drug, tirzepatide, in inducing weight reduction in adults with obesity or overweight plus a weight-related complication...
  29. madman

    Tirzepatide Once Weekly for the Treatment of Obesity

    Tirzepatide Once Weekly for the Treatment of Obesity (2022) Ania M. Jastreboff, M.D., Ph.D., Louis J. Aronne, M.D., Nadia N. Ahmad, M.D., M.P.H., Sean Wharton, M.D., Pharm.D., Lisa Connery, M.D., Breno Alves, M.D., Arihiro Kiyosue, M.D., Ph.D., Shuyu Zhang, M.S., Bing Liu, Ph.D., Mathijs C...
  30. madman

    Tirzepatide: A New Treatment for Diabetes

Free ExcelMale Downloads: men's health guides, eBooks and resources

Sponsors

obesity

obesity

ExcelMale Newsletter Signup

Back
Top